EUVIMEDEUVIMED entdecken
Crossref

Revealing distinct treatment mechanisms and outcome correlations in patients with interstitial cystitis/bladder pain syndrome after different bladder therapies through urinary biomarker analysis

Yu-Chieh Chiu, Ping-Chiao Tsai, Jia-Fong Jhang, Hann-Chorng Kuo

International Urology and Nephrology · 29.01.2025 · 57 (7) · 2073-2080

DOI: 10.1007/s11255-025-04388-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Urology and Nephrology, online erschienen am 29.01.2025. Verfasst von Yu-Chieh Chiu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Education, Medical Administration Office, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, 970, Taiwan. Hauptthemen laut MEDLINE: Cystitis, Interstitial, Botulinum Toxins, Type A, Cytokines, Extracorporeal Shockwave Therapy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Buddhist Tzu Chi Medical Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Urinary cytokine changes may serve as biomarkers to assess treatment outcomes for interstitial cystitis/bladder pain syndrome (IC/BPS). This study analyzed the changes in urinary cytokines following various bladder therapies and explored their clinical significance in therapeutic mechanisms. METHODS: A total of 122 patients with IC/BPS treated with platelet-rich plasma (PRP), botulinum toxin-A (BoTN-A), hyaluronic acid (HA), or low-energy shock wave (LESW) were evaluated. Urinary inflammatory and oxidative stress biomarkers were measured at baseline and at 3 months posttreatment. Treatment outcomes were assessed using the Global Response Assessment (GRA), a 10-point visual analog score for pain, and the O'Leary-Saint Symptom Score (OSS). A GRA ≥ 2 was considered indicative of effective treatment. RESULTS: Significant symptom improvement was observed in patients treated with PRP and BoNT-A but not with LESW or HA. At 3 months post-treatment, PRP therapy led to decreased urinary 8-isoprostane and total antioxidant capacity levels, while BoNT-A therapy reduced monocyte chemotactic protein-1 and 8-hydroxy-2'-deoxyguanosine levels. HA therapy did not alter urinary biomarker levels, whereas LESW therapy increased macrophage inflammatory protein-1 beta and tumor necrosis factor-α levels. Patients with significant urinary biomarker reductions (GRA ≥ 2) demonstrated clinical improvement at 3 months. CONCLUSION: PRP or BoNT-A exhibits anti-inflammatory effects, reflected by reductions in urinary cytokine levels, correlating with positive treatment outcomes. Urinary cytokine changes may play a role to evaluate the mechanisms of action of various treatments in patients with IC/BPS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystitis, InterstitialBotulinum Toxins, Type ACytokinesExtracorporeal Shockwave TherapyHumansBiomarkersFemaleMiddle AgedMaleHyaluronic AcidTreatment OutcomeAdultAged

Stichwörter der Autor:innen

BiomarkerBladder pain syndromeCytokineInterstitial cystitis

Substanzen

BiomarkersBotulinum Toxins, Type AHyaluronic AcidCytokines

Autor:innen und Institutionen

  • Department of Medical Education, Medical Administration Office, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, 970, Taiwan.
  • Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, Hualien, Taiwan.
  • Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, Hualien, Taiwan. hck@tzuchi.com.tw.

Förderung

  • Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
  • Buddhist Tzu Chi Medical Foundation

Zitieren

APA

Chiu, Y. C., Tsai, P. C., Jhang, J. F., & Kuo, H. C. (2025). Revealing distinct treatment mechanisms and outcome correlations in patients with interstitial cystitis/bladder pain syndrome after different bladder therapies through urinary biomarker analysis. International Urology and Nephrology, 57(7), 2073-2080. https://doi.org/10.1007/s11255-025-04388-3

Vancouver

Chiu YC, Tsai PC, Jhang JF, Kuo HC. Revealing distinct treatment mechanisms and outcome correlations in patients with interstitial cystitis/bladder pain syndrome after different bladder therapies through urinary biomarker analysis. International Urology and Nephrology. 2025;57(7):2073-2080. doi:10.1007/s11255-025-04388-3

BibTeX
@article{Chiu2025,
  author = {Chiu, Yu-Chieh and Tsai, Ping-Chiao and Jhang, Jia-Fong and Kuo, Hann-Chorng},
  title = {Revealing distinct treatment mechanisms and outcome correlations in patients with interstitial cystitis/bladder pain syndrome after different bladder therapies through urinary biomarker analysis},
  journal = {International Urology and Nephrology},
  year = {2025},
  volume = {57},
  number = {7},
  pages = {2073--2080},
  doi = {10.1007/s11255-025-04388-3}
}
Kostenlos starten →